Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate.
Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux.
Tissue factor pathway inhibitor and the current concept of blood coagulation.
Tissue factor pathway inhibitor and the revised theory of coagulation.
Future possibilities in the regulation of the extrinsic pathway: rFVIIa and TFPI.
Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII.
"Normal" thrombin generation.
Reduction of factor FVIIa activity during heparin therapy. Evidence for assay interactions with tissue factor pathway inhibitor and antithrombin.
Newer concepts of blood coagulation.
Prescribing Info - Questions - Drug Info - Links - PDA Software - Article Summaries - Slideshows - Review Articles - What's New
© Copyright 1999-2020 All Rights Reserved.